Pharmacists across British Columbia will have an important role to play in improving the care and safety of their patients as First Nations Health Authority patients become BC PharmaCare beneficiaries on October 1, 2017.
Each year, the UBC Faculty of Pharmaceutical Sciences Alumni Agent of Change Award recognizes one outstanding member of the Pharm Sci alumni family for their remarkable achievements in a clinical, community, education, or research field.
The practice of pharmacy is in a constant state of flux. From changes in healthcare legislation, to new practices, knowledge and research, pharmacy practice is always advancing at a rapid pace. And as professionals, we have to keep up!
Are you a pharmacist or technician with cancer patients in your general practice? Are you a new practitioner or pharmacy student? Are you interested in foundational oncology education? If you answered yes to any of these questions, plan to attend the CAPhO Oncology Fundamentals Day (OFD17), taking place on Saturday, September 30, 2017 as a full day online learning event.
The BC Centre on Substance Use (BCCSU), in collaboration with the BC Ministry of Health, has released a new Guideline for the Clinical Management of Opioid Use Disorder. Effective June 5, 2017, this guideline is the provincial reference tool for all health care professionals in BC involved in treating patients with opioid use disorders.
A Fentanyl patch is a medication adhesive transdermal patch that is placed on the skin to deliver a specific dose of fentanyl through the skin. Improper disposal of these patches is a risk for diversion, illicit use and overdose. Accidental exposure to the patches can also cause serious harm to members of the public including children, pets, sanitation workers, as well as our water supply.
Did you know that the combination of clarithromycin and colchicine can cause serious adverse events such as rhabdomyolysis, pancytopenia and even death? Even though concomitant prescribing of the two drugs prompts the highest level of drug interaction severity, “major” or “severe”, in all major pharmacy software programs, patients are still being dispensed this combination.
PainBC’s integrated approach to pain management includes helping patients find the most effective medications to manage their chronic pain. Well-structured medication trials with collaboration between prescribers and pharmacists plays an important role in helping identify the most effective drug therapy for a patient.
The College has received a number of inquiries about when our registrants are free from their responsibilities as pharmacy professionals. This seems like an odd question, but it’s come up more than once and in a number of different contexts...
Earlier this year, the BCCSU and the Ministry of Health (MoH) released a new Guideline for the Clinical Management of Opioid Use Disorder. Starting on June 5, 2017, this guideline will become the provincial reference tool for all health care professionals in BC involved in treating patients with opioid use disorders, and the management of the Provincial Methadone Program will transition from the College of Physicians and Surgeons of British Columbia to the BCCSU.
It’s important to be able to provide continuity of care for patients in provincial correctional centres when they are released into the community. For this reason, BC Corrections wants to work with community pharmacies to ensure patients can receive the medications they need upon release through collaboration with the treating physicians.